STBT5:Volunteer Assignments and Opportunities: Difference between revisions

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
← Older edit
VisualWikitext
Kathleen.Schieffer (talk | contribs)
autoreview, editor
141 edits
No edit summary
Kathleen.Schieffer (talk | contribs)
autoreview, editor
141 edits
No edit summary
 
(47 intermediate revisions by 3 users not shown)
Line 160: Line 160:
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
|Disease
|Disease
|Kauser Begum Ravishankar (trainee), with Katie
|2/25/2026
|5/25/2026
|PENDING
|
|
|
|Katie Schieffer
|
|
|
|
|
|
|
|
Line 182: Line 182:
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
|Disease
|Disease
|Karla Sofía Peláez Valdés (trainee);
Katie Schieffer (mentor)
|3/1/2026
|
|
|PENDING
|
|
|
|Katie Schieffer
|
|
|
|
|
|
|
Line 226: Line 227:
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
|[[STBT5:Proliferative_fasciitis_and_proliferative_myositis|Proliferative fasciitis and proliferative myositis]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|12/8/2025
|
|Katie Schieffer
|
|12/8/2025
|
|Minimal genetic content added
|-
|-
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
Line 247: Line 248:
|-
|-
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/16/2025
|Katie Schieffer
|10/16/2025
|No genetic association
|-
|[[STBT5:Elastofibroma|Elastofibroma]]
|Disease
|Disease
|
|
Line 257: Line 269:
|
|
|-
|-
|[[STBT5:Elastofibroma|Elastofibroma]]
|-
|Disease
|
|
|
|
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Date Assigned to Author'''
Line 289: Line 290:
|-
|-
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|9/22/2025
|Katie Schieffer
|9/22/2025
|No genetic association
|-
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
|Disease
|Disease
|
|
Line 299: Line 311:
|
|
|-
|-
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/16/2025
|Katie Schieffer
|10/16/2025
|No genetic association
|-
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|Disease
|Disease
|
|
Line 310: Line 333:
|
|
|-
|-
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
|Disease
|Disease
|
|
Line 321: Line 344:
|
|
|-
|-
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
|Disease
|Disease
|
|
Line 332: Line 355:
|
|
|-
|-
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
|Disease
|Disease
|
|
Line 343: Line 366:
|
|
|-
|-
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
|Disease
|Disease
|
|
Line 354: Line 377:
|
|
|-
|-
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
|Disease
|Disease
|
|
Line 365: Line 408:
|
|
|-
|-
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
|Disease
|Disease
|
|
Line 376: Line 419:
|
|
|-
|-
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/8/2025
|Katie Schieffer
|12/8/2025
|No genetic association
|-
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
|Disease
|Disease
|
|
Line 387: Line 441:
|
|
|-
|-
|-
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|Disease
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
|Disease
|
|
|
|
Line 407: Line 452:
|
|
|-
|-
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|Minimal genetic content added
|-
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|Disease
|Disease
|
|
Line 418: Line 474:
|
|
|-
|-
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
|Disease
|Disease
|
|
Line 429: Line 485:
|
|
|-
|-
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
|Disease
|Disease
|
|
Line 440: Line 496:
|
|
|-
|-
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
|Disease
|Disease
|He Fang
|2/19/2026
|5/20/2026
|PENDING
|
|
|
|Katie Schieffer
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|Disease
|Yiting Li (trainee);
Shashirekha Shetty (mentor)
|9/24/2025
|12/24/2025
|COMPLETE
|12/18/2025
|Katie Schieffer
|12/18/2025
|
|
|-
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
|Disease
|Katherine Geiersbach
|8/11/2023
|11/11/2203
|COMPLETE
|1/8/2025
|Katherine Geiersbach
|1/8/2025
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
|Disease
|Disease
|
|
Line 473: Line 561:
|
|
|-
|-
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|3/1/2026
|6/30/2026
|COMPLETE
|3/3/2026
|Katie Schieffer
|3/4/2026
|
|-
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
|Disease
|Katie Schieffer
|4/21/2025
|10/1/2025
|COMPLETE
|9/18/2025
|Katie Schieffer
|9/18/2025
|
|-
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
|Disease
|Disease
|
|
Line 484: Line 606:
|
|
|-
|-
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
|Disease
|Disease
|
|
Line 495: Line 617:
|
|
|-
|-
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
|Disease
|Disease
|
|
Line 515: Line 637:
!'''Notes'''
!'''Notes'''
|-
|-
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
|Disease
|Shashi Shetty and Reba Daniel (resident)
|2/21/2024
|
|PENDING
|
|Katherine Geiersbach
|
|Template added 2/21/2024
|-
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
|Disease
|Disease
|
|
Line 537: Line 648:
|
|
|-
|-
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
|Disease
|Disease
|
|
Line 548: Line 659:
|
|
|-
|-
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|12/8/2025
|
|Katie Schieffer
|
|12/8/2025
|
|No genetic association
|-
|-
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/10/2025
|Katie Schieffer
|11/10/2025
|No genetic association
|-
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/10/2025
|Katie Schieffer
|12/10/2025
|No genetic association
|-
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|Disease
|
|
|
|
|
|
Line 570: Line 714:
|
|
|-
|-
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|Disease
|Disease
|Katie Schieffer
|Katie Schieffer
|4/21/2025
|9/21/2025
|10/1/2025
|12/21/2025
|PENDING
|COMPLETE
|
|12/10/2025
|
|Katie Schieffer
|
|12/10/2025
|
|No genetic association
|-
|-
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|Disease
|Disease
|
|
Line 592: Line 736:
|
|
|-
|-
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|Disease
|Disease
|
|
Line 603: Line 747:
|
|
|-
|-
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|Disease
|Disease
|
|
Line 614: Line 767:
|
|
|-
|-
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
|Disease
|Disease
|
|
Line 625: Line 778:
|
|
|-
|-
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|Minimal genetic content added
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
!'''Date Assigned to Author'''
|Disease
!'''Target Completion Date'''
|Katie Schieffer
!'''Author Content (Pending or Complete)'''
|9/21/2025
!'''Date Completed by Author'''!!'''Associate Editor'''
|12/21/2025
!'''Date of Last Editor Review'''
|COMPLETE
!'''Notes'''
|12/11/2025
|Katie Schieffer
|12/11/2025
|Minimal genetic content added
|-
|-
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|Disease
|Disease
|
|
Line 645: Line 811:
|
|
|-
|-
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|Disease
|Disease
|
|
Line 656: Line 822:
|
|
|-
|-
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
|Disease
|Disease
|
|
Line 667: Line 833:
|
|
|-
|-
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|Disease
|Disease
|
|
Line 678: Line 844:
|
|
|-
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|[[STBT5:Angiosarcoma|Angiosarcoma]]
|Disease
|Disease
|
|
Line 689: Line 855:
|
|
|-
|-
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|[[STBT5:Glomus_tumour|Glomus tumour]]
|Disease
|Disease
|
|
Line 700: Line 866:
|
|
|-
|-
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
|Disease
|Disease
|
|
Line 711: Line 886:
|
|
|-
|-
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
|Disease
|Disease
|
|
Line 722: Line 897:
|
|
|-
|-
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|[[STBT5:Leiomyoma|Leiomyoma]]
|Disease
|Disease
|
|
Line 733: Line 908:
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|12/12/2025
|
|Katie Schieffer
|
|12/12/2025
|
|No genetic association
|-
|-
|-
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|Disease
|Disease
|
|
Line 764: Line 930:
|
|
|-
|-
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
|Disease
|Disease
|
|
Line 775: Line 941:
|
|
|-
|-
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
|Disease
|Disease
|
|
Line 786: Line 952:
|
|
|-
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 797: Line 963:
|
|
|-
|-
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 808: Line 974:
|
|
|-
|-
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 819: Line 985:
|
|
|-
|-
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 830: Line 1,005:
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
|Disease
|Disease
|
|
Line 841: Line 1,016:
|
|
|-
|-
|[[STBT5:Angiosarcoma|Angiosarcoma]]
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
|Disease
|Shanmugapriya Veeralakumar (trainee); Katie as mentor
|2/23/2026
|
|PENDING
|
|Katie Schieffer
|
|
|-
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
|Disease
|Disease
|
|
Line 852: Line 1,038:
|
|
|-
|-
|[[STBT5:Glomus_tumour|Glomus tumour]]
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
|Disease
|Disease
|
|
Line 863: Line 1,049:
|
|
|-
|-
|-
|[[STBT5:Schwannoma|Schwannoma]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|Disease
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
|Disease
|
|
|
|
|
|
Line 883: Line 1,060:
|
|
|-
|-
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
|[[STBT5:Neurofibroma|Neurofibroma]]
|Disease
|Disease
|
|
Line 894: Line 1,071:
|
|
|-
|-
|[[STBT5:Leiomyoma|Leiomyoma]]
|[[STBT5:Perineurioma|Perineurioma]]
|Disease
|Disease
|
|
Line 905: Line 1,082:
|
|
|-
|-
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
|Disease
|Disease
|
|
Line 916: Line 1,093:
|
|
|-
|-
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|12/11/2025
|
|Katie Schieffer
|
|12/11/2025
|
|No genetic association
|-
|-
|-
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/11/2025
|Katie Schieffer
|12/11/2025
|No genetic association
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|Disease
|Disease
|
|
Line 938: Line 1,135:
|
|
|-
|-
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|Disease
|Disease
|
|
Line 949: Line 1,146:
|
|
|-
|-
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
|Disease
|Disease
|
|
Line 960: Line 1,157:
|
|
|-
|-
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|Disease
|
|
Line 971: Line 1,168:
|
|
|-
|-
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|Disease
|
|
Line 982: Line 1,179:
|
|
|-
|-
|-
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|Disease
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
|Disease
|
|
|
|
|
|
Line 1,002: Line 1,190:
|
|
|-
|-
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|No genetic association
|-
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|Disease
|Disease
|
|
Line 1,013: Line 1,212:
|
|
|-
|-
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|Disease
|Disease
|
|
Line 1,024: Line 1,223:
|
|
|-
|-
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
|Disease
|Disease
|
|
Line 1,035: Line 1,243:
|
|
|-
|-
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
|Disease
|Disease
|
|
Line 1,046: Line 1,254:
|
|
|-
|-
|[[STBT5:Schwannoma|Schwannoma]]
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
|Disease
|Disease
|
|
Line 1,057: Line 1,265:
|
|
|-
|-
|[[STBT5:Neurofibroma|Neurofibroma]]
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
|Disease
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|9/11/2025
|12/11/2025
|COMPLETE
|12/29/2026
|Katie Schieffer
|1/7/2026
|
|
|
|-
|
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|
|Disease
|Mokhtar Abdelhammed, MD (trainee);
Katie Schieffer (mentor)
|3/1/2026
|6/30/2026
|PENDING
|
|
|
|
Line 1,068: Line 1,289:
|
|
|-
|-
|[[STBT5:Perineurioma|Perineurioma]]
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
|Disease
|Disease
|
|
Line 1,079: Line 1,300:
|
|
|-
|-
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|Disease
|James Solomon, MD, PhD
|2/20/2022
|12/9/2025
|COMPLETE
|2/26/2026
|Katie Schieffer
|2/26/2026
|
|-
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
|Disease
|Disease
|
|
Line 1,090: Line 1,322:
|
|
|-
|-
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|Disease
|Disease
|
|
Line 1,101: Line 1,333:
|
|
|-
|-
|-
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
|Disease
|Maxine Sutcliffe, PhD
|10/13/2025
|12/31/2025
|COMPLETE
|12/24/2025
|Katie Schieffer
|12/24/2025
|
|-
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
|Disease
|
|
|
|
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Date Assigned to Author'''
Line 1,110: Line 1,364:
!'''Notes'''
!'''Notes'''
|-
|-
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,121: Line 1,375:
|
|
|-
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|Disease
|Disease
|
|Maxine Sutcliffe, PhD
|
|1/12/2026
|
|4/12/2026
|
|PENDING
|
|
|
|
Line 1,132: Line 1,386:
|
|
|-
|-
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|Disease
|Disease
|
|
Line 1,143: Line 1,397:
|
|
|-
|-
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
|[[STBT5:PEComa|PEComa]]
|Disease
|Disease
|
|
Line 1,154: Line 1,408:
|
|
|-
|-
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
|Disease
|Disease
|
|
Line 1,165: Line 1,419:
|
|
|-
|-
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
|Disease
|Disease
|
|
Line 1,176: Line 1,430:
|
|
|-
|-
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
|Disease
|
|
====CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)====
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
|
----
|
|
----
|
----
|
|
----
|-
|-
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|Disease
|Sadeem Qdaisat (trainee); Eric McGinnis (mentor)
|10/1/2023
|12/9/2025
|PENDING
|
|
|
|Katie Schieffer
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
|Disease
|Disease
|
|
Line 1,209: Line 1,473:
|
|
|-
|-
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|Disease
|
|
Line 1,217: Line 1,481:
|
|
|
|
|
|
|-
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
|Disease
|He Fang
|2/19/2026
|8/20/2026
|PENDING
|
|Katie Schieffer
|
|
|
|
Line 1,229: Line 1,504:
!'''Notes'''
!'''Notes'''
|-
|-
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
|Disease
|
|
====CHAPTER 4 (BONE TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
|Disease
|
|
|
|
|
|
|
|
----
|
|
----
|-
|-
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/12/2025
|Katie Schieffer
|12/12/2025
|No genetic association
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|12/8/2025
|Katie Schieffer
|12/8/2025
|
|-
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|Disease
|Disease
|
|
Line 1,262: Line 1,558:
|
|
|-
|-
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
|[[STBT5:Enchondroma|Enchondroma]]
|Disease
|Disease
|
|
Line 1,273: Line 1,569:
|
|
|-
|-
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|[[STBT5:Osteochondroma|Osteochondroma]]
|Disease
|Disease
|
|
Line 1,284: Line 1,580:
|
|
|-
|-
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|
|-
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|Disease
|Disease
|
|
Line 1,295: Line 1,602:
|
|
|-
|-
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|Disease
|James Solomon, MD, PhD
|2/20/2022
|12/9/2025
|PENDING
|
|Katie Schieffer
|
|
|-
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
|Disease
|Disease
|
|
Line 1,317: Line 1,613:
|
|
|-
|-
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|Disease
|Disease
|
|
Line 1,328: Line 1,624:
|
|
|-
|-
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/31/2025
|
|COMPLETE
|
|11/14/2025
|
|Katie Schieffer
|
|11/14/2025
|
|
|-
|-
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|Disease
|
|
Line 1,359: Line 1,655:
!'''Notes'''
!'''Notes'''
|-
|-
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|
|
Line 1,370: Line 1,666:
|
|
|-
|-
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|
|
Line 1,381: Line 1,677:
|
|
|-
|-
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,392: Line 1,688:
|
|
|-
|-
|[[STBT5:PEComa|PEComa]]
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,403: Line 1,699:
|
|
|-
|-
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,414: Line 1,710:
|
|
|-
|-
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,425: Line 1,721:
|
|
|-
|-
|[[STBT5:Osteoma|Osteoma]]
|Disease
|
|
|
|
|
|
====CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)====
|
|
----
|
|
----
|
|
----
|-
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|Disease
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|Sadeem Qdaisat
|10/1/23
|12/9/2025
|PENDING
|
|
|Working with Eric McGinnis
|
|
|2021 template added
|-
|-
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|Disease
|Disease
|
|
Line 1,468: Line 1,754:
|
|
|-
|-
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|Disease
|Ganesh Pandurang, MD
|2/28/24
|
|PENDING
|
|Katherine Geiersbach
|
|
|-
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
|Disease
|Disease
|
|
Line 1,499: Line 1,774:
!'''Notes'''
!'''Notes'''
|-
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|Disease
|Fang Fang (trainee); Katie Schieffer (mentor)
|11/19/2025
|4/15/2026
|PENDING
|
|Katie Schieffer
|
|
====CHAPTER 4 (BONE TUMOURS)====
|
|
----
|-
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|Disease
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|Disease
|Disease
|
|
Line 1,531: Line 1,807:
|
|
|-
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|Disease
|Disease
|
|
Line 1,542: Line 1,818:
|
|
|-
|-
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|Disease
|Disease
|
|
Line 1,553: Line 1,829:
|
|
|-
|-
|[[STBT5:Enchondroma|Enchondroma]]
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|Disease
|Disease
|
|
Line 1,564: Line 1,840:
|
|
|-
|-
|[[STBT5:Osteochondroma|Osteochondroma]]
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|Disease
|Disease
|
|
Line 1,575: Line 1,851:
|
|
|-
|-
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|Disease
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|
|COMPLETE
|
|11/14/2025
|
|Katie Schieffer
|
|11/14/2025
|
|No genetic association
|-
|-
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|Disease
|[[STBT5:Epithelioid haemangioma|See STBT5: Epithelioid haemangioma page]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|Disease
|[[STBT5:Epithelioid haemangioendothelioma|See STBT5: Epithelioid haemangioendothelioma page]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|[[STBT5:Angiosarcoma|See STBT5: Angiosarcoma page]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|-
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|Disease
|
|
Line 1,597: Line 1,915:
|
|
|-
|-
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|Disease
|
|
Line 1,608: Line 1,926:
|
|
|-
|-
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|Disease
|Disease
|
|
Line 1,619: Line 1,937:
|
|
|-
|-
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|Disease
|Disease
|
|
Line 1,630: Line 1,948:
|
|
|-
|-
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|Disease
|
|
Line 1,641: Line 1,959:
|
|
|-
|-
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|No genetic association, early genetic studies referenced
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|
|
Line 1,661: Line 1,981:
|
|
|-
|-
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|11/14/2025
|Katie Schieffer
|11/14/2025
|No genetic association
|-
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/22/2025
|Katie Schieffer
|10/22/2025
|
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|Disease
|
|
Line 1,683: Line 2,023:
|
|
|-
|-
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|
|
|-
|
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|
|Disease
|
|Katie Schieffer
|
|9/21/2025
|
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|
|-
|-
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|Disease
|
|
Line 1,705: Line 2,056:
|
|
|-
|-
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|Disease
|
|
Line 1,716: Line 2,067:
|
|
|-
|-
|[[STBT5:Osteoma|Osteoma]]
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|Disease
|[[STBT5:Leiomyosarcoma|See STBT5: Leiomyosarcoma page]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|Disease
|Maxine Sutcliffe
|2/23/2026
|4/12/2026
|COMPLETE
|4/27/2026
|Katie Schieffer
|4/28/2026
|
|
|-
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|Katie Schieffer
|9/21/2025
|12/21/2025
|COMPLETE
|10/21/2025
|Katie Schieffer
|10/21/2025
|
|
|
|-
|
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|
|Disease
|
|
|-
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|Disease
|
|
|
|
Line 1,738: Line 2,111:
|
|
|-
|-
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|Disease
|Disease
|
|
Line 1,769: Line 2,131:
!'''Notes'''
!'''Notes'''
|-
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
|Disease
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|
|
====CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)====
|
|
----
|
|
----
|
|
----
|
|
|-
----
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|Disease
|
|
|
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|[[STBT5:Enchondromatosis|Enchondromatosis]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|-
|-
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|-
|
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|-
|
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|
|
|
|
|
|-
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|
====CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|-
|[[STBT5:Enchondromatosis|Enchondromatosis]]
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
Line 2,200: Line 2,249:
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
|Disease
|
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
|[[STBT5:Werner_syndrome|Werner syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
Line 2,233: Line 2,260:
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Werner_syndrome|Werner syndrome]]
|Disease
|
|
|
|
|
|
|
|
|
|-
|-
|}<br />
|}<br />

Latest revision as of 04:20, 28 April 2026

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (SOFT TISSUE TUMOURS)
Lipoma Disease
Lipomatosis Disease
Lipomatosis of nerve Disease
Lipoblastoma and lipoblastomatosis Disease
Angiolipoma Disease
Myolipoma of soft tissue Disease
Chondroid lipoma Disease
Spindle cell lipoma and pleomorphic lipoma Disease
Hibernoma Disease
Atypical spindle cell / pleomorphic lipomatous tumour Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Atypical lipomatous tumour / well-differentiated liposarcoma Disease Kauser Begum Ravishankar (trainee), with Katie 2/25/2026 5/25/2026 PENDING Katie Schieffer
Dedifferentiated liposarcoma Disease
Myxoid liposarcoma Disease Karla Sofía Peláez Valdés (trainee);

Katie Schieffer (mentor)

3/1/2026 PENDING Katie Schieffer
Pleomorphic liposarcoma Disease
Myxoid pleomorphic liposarcoma Disease
Nodular fasciitis Disease
Proliferative fasciitis and proliferative myositis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/8/2025 Katie Schieffer 12/8/2025 Minimal genetic content added
Myositis ossificans and fibro-osseous pseudotumour of digits Disease
Ischaemic fasciitis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/16/2025 Katie Schieffer 10/16/2025 No genetic association
Elastofibroma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Fibrous hamartoma of infancy Disease
Fibromatosis colli Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 9/22/2025 Katie Schieffer 9/22/2025 No genetic association
Juvenile hyaline fibromatosis Disease
Inclusion body fibromatosis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/16/2025 Katie Schieffer 10/16/2025 No genetic association
Fibroma of tendon sheath Disease
Desmoplastic fibroblastoma Disease
Myofibroblastoma Disease
Calcifying aponeurotic fibroma Disease
EWSR1-SMAD3-positive fibroblastic tumour (emerging) Disease
Angiomyofibroblastoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/21/2025 Katie Schieffer 10/21/2025
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Cellular angiofibroma Disease
Angiofibroma of soft tissue Disease
Nuchal-type fibroma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/8/2025 Katie Schieffer 12/8/2025 No genetic association
Acral fibromyxoma Disease
Gardner fibroma Disease
Palmar fibromatosis and plantar fibromatosis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/12/2025 Katie Schieffer 12/12/2025 Minimal genetic content added
Desmoid fibromatosis Disease
Lipofibromatosis Disease
Giant cell fibroblastoma Disease
Dermatofibrosarcoma protuberans Disease He Fang 2/19/2026 5/20/2026 PENDING Katie Schieffer
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Solitary fibrous tumour Disease Yiting Li (trainee);

Shashirekha Shetty (mentor)

9/24/2025 12/24/2025 COMPLETE 12/18/2025 Katie Schieffer 12/18/2025
Inflammatory myofibroblastic tumour Disease Katherine Geiersbach 8/11/2023 11/11/2203 COMPLETE 1/8/2025 Katherine Geiersbach 1/8/2025
Low-grade myofibroblastic sarcoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/10/2025 Katie Schieffer 12/10/2025 No genetic association
Superficial CD34-positive fibroblastic tumour Disease
Myxoinflammatory fibroblastic sarcoma Disease Mokhtar Abdelhammed, MD (trainee);

Katie Schieffer (mentor)

3/1/2026 6/30/2026 COMPLETE 3/3/2026 Katie Schieffer 3/4/2026
Infantile fibrosarcoma Disease Katie Schieffer 4/21/2025 10/1/2025 COMPLETE 9/18/2025 Katie Schieffer 9/18/2025
Adult fibrosarcoma Disease
Myxofibrosarcoma Disease
Low-grade fibromyxoid sarcoma Disease
Sclerosing epithelioid fibrosarcoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Tenosynovial giant cell tumour Disease
Deep fibrous histiocytoma Disease
Plexiform fibrohistiocytic tumour Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/8/2025 Katie Schieffer 12/8/2025 No genetic association
Giant cell tumour of soft tissue Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/10/2025 Katie Schieffer 12/10/2025 No genetic association
Synovial haemangioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/10/2025 Katie Schieffer 11/10/2025 No genetic association
Intramuscular angioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/10/2025 Katie Schieffer 12/10/2025 No genetic association
Arteriovenous malformation/haemangioma Disease
Venous haemangioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/10/2025 Katie Schieffer 12/10/2025 No genetic association
Anastomosing haemangioma Disease
Epithelioid haemangioma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Lymphangioma and lymphangiomatosis Disease
Tufted angioma and kaposiform haemangioendothelioma Disease
Retiform haemangioendothelioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/11/2025 Katie Schieffer 12/11/2025 Minimal genetic content added
Papillary intralymphatic angioendothelioma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/11/2025 Katie Schieffer 12/11/2025 Minimal genetic content added
Composite haemangioendothelioma Disease
Kaposi sarcoma Disease
Pseudomyogenic haemangioendothelioma Disease
Epithelioid haemangioendothelioma Disease
Angiosarcoma Disease
Glomus tumour Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Myopericytoma, including myofibroma Disease
Angioleiomyoma Disease
Leiomyoma Disease
EBV-associated smooth muscle tumour Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/12/2025 Katie Schieffer 12/12/2025 No genetic association
Inflammatory leiomyosarcoma Disease
Leiomyosarcoma Disease
Rhabdomyoma Disease
Embryonal rhabdomyosarcoma Disease
Alveolar rhabdomyosarcoma Disease
Pleomorphic rhabdomyosarcoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Spindle cell / sclerosing rhabdomyosarcoma Disease
Ectomesenchymoma Disease
Gastrointestinal stromal tumour Disease Shanmugapriya Veeralakumar (trainee); Katie as mentor 2/23/2026 PENDING Katie Schieffer
Soft tissue chondroma Disease
Extraskeletal osteosarcoma Disease
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Granular cell tumour Disease
Dermal nerve sheath myxoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/11/2025 Katie Schieffer 12/11/2025 No genetic association
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Solitary circumscribed neuroma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/11/2025 Katie Schieffer 12/11/2025 No genetic association
Ectopic meningioma and meningothelial hamartoma Disease
Benign triton tumour / neuromuscular choristoma Disease
Hybrid nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Malignant melanotic nerve sheath tumour Disease
Intramuscular myxoma Disease
Juxta-articular myxoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/12/2025 Katie Schieffer 12/12/2025 No genetic association
Deep (aggressive) angiomyxoma Disease
Atypical fibroxanthoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Angiomatoid fibrous histiocytoma Disease
Ossifying fibromyxoid tumour Disease
Myoepithelioma, myoepithelial carcinoma, and mixed tumour Disease
Pleomorphic hyalinizing angiectatic tumour of soft parts Disease Mokhtar Abdelhammed, MD (trainee);

Katie Schieffer (mentor)

9/11/2025 12/11/2025 COMPLETE 12/29/2026 Katie Schieffer 1/7/2026
Haemosiderotic fibrolipomatous tumour Disease Mokhtar Abdelhammed, MD (trainee);

Katie Schieffer (mentor)

3/1/2026 6/30/2026 PENDING
Phosphaturic mesenchymal tumour Disease
NTRK-rearranged spindle cell neoplasm (emerging) Disease James Solomon, MD, PhD 2/20/2022 12/9/2025 COMPLETE 2/26/2026 Katie Schieffer 2/26/2026
Synovial sarcoma Disease
Epithelioid sarcoma Disease
Alveolar soft part sarcoma Disease Maxine Sutcliffe, PhD 10/13/2025 12/31/2025 COMPLETE 12/24/2025 Katie Schieffer 12/24/2025
Clear cell sarcoma of soft tissue Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Extraskeletal myxoid chondrosarcoma Disease
Desmoplastic small round cell tumour Disease Maxine Sutcliffe, PhD 1/12/2026 4/12/2026 PENDING
Extrarenal rhabdoid tumour Disease
PEComa Disease
Intimal sarcoma Disease
Undifferentiated sarcoma Disease

CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)
Ewing sarcoma Disease Sadeem Qdaisat (trainee); Eric McGinnis (mentor) 10/1/2023 12/9/2025 PENDING Katie Schieffer
Round cell sarcoma with EWSR1-non-ETS fusions Disease
CIC-rearranged sarcoma Disease
Sarcoma with BCOR genetic alterations Disease He Fang 2/19/2026 8/20/2026 PENDING Katie Schieffer
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 4 (BONE TUMOURS)
Subungual exostosis Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/12/2025 Katie Schieffer 12/12/2025 No genetic association
Bizarre parosteal osteochondromatous proliferation Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 12/8/2025 Katie Schieffer 12/8/2025
Periosteal chondroma Disease
Enchondroma Disease
Osteochondroma Disease
Chondroblastoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025
Chondromyxoid fibroma Disease
Osteochondromyxoma Disease
Synovial chondromatosis Disease
Central atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease Katie Schieffer 9/21/2025 12/31/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025
Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1 Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Central chondrosarcoma, grades 2 and 3 Disease
Secondary peripheral chondrosarcoma, grades 2 and 3 Disease
Periosteal chondrosarcoma Disease
Clear cell chondrosarcoma Disease
Mesenchymal chondrosarcoma Disease
Dedifferentiated chondrosarcoma Disease
Osteoma Disease
Osteoid osteoma Disease
Osteoblastoma Disease
Low-grade central osteosarcoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Osteosarcoma Disease Fang Fang (trainee); Katie Schieffer (mentor) 11/19/2025 4/15/2026 PENDING Katie Schieffer
Parosteal osteosarcoma Disease
Periosteal osteosarcoma Disease
High-grade surface osteosarcoma Disease
Secondary osteosarcoma Disease
Desmoplastic fibroma of bone Disease
Fibrosarcoma of bone Disease
Haemangioma of bone Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025 No genetic association
Epithelioid haemangioma of bone Disease See STBT5: Epithelioid haemangioma page N/A N/A N/A N/A N/A N/A
Epithelioid haemangioendothelioma of bone Disease See STBT5: Epithelioid haemangioendothelioma page N/A N/A N/A N/A N/A N/A
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Angiosarcoma of bone Disease See STBT5: Angiosarcoma page N/A N/A N/A N/A N/A N/A
Aneurysmal bone cyst Disease
Giant cell tumour of bone Disease
Non-ossifying fibroma Disease
Benign notochordal cell tumour Disease
Conventional chordoma Disease
Dedifferentiated chordoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025 No genetic association, early genetic studies referenced
Poorly differentiated chordoma Disease
Chondromesenchymal hamartoma of chest wall Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 11/14/2025 Katie Schieffer 11/14/2025 No genetic association
Osteofibrous dysplasia Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/22/2025 Katie Schieffer 10/22/2025
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Adamantinoma of long bones Disease
Simple bone cyst Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/21/2025 Katie Schieffer 10/21/2025
Fibrocartilaginous mesenchymoma Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/21/2025 Katie Schieffer 10/21/2025
Fibrous dysplasia Disease
Lipoma and hibernoma of bone Disease
Leiomyosarcoma of bone Disease See STBT5: Leiomyosarcoma page N/A N/A N/A N/A N/A N/A
Undifferentiated pleomorphic sarcoma Disease Maxine Sutcliffe 2/23/2026 4/12/2026 COMPLETE 4/27/2026 Katie Schieffer 4/28/2026
Bone metastases Disease Katie Schieffer 9/21/2025 12/21/2025 COMPLETE 10/21/2025 Katie Schieffer 10/21/2025
Solitary plasmacytoma of bone Disease
Primary non-Hodgkin lymphoma of bone Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Langerhans cell histiocytosis Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Erdheim-Chester disease Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Rosai-Dorfman disease Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A

CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)
Enchondromatosis Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Li-Fraumeni syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
McCune-Albright syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Multiple osteochondromas Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Rothmund-Thomson syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Werner syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A


Retrieved from "https://content.ccga.io/index.php?title=STBT5:Volunteer_Assignments_and_Opportunities&oldid=21174"